Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethyl Methylphosphonate SCHEMBL35767 | 0.83 | — | — | |
| Dimethyl Methylphosphonate SCHEMBL30393703 | 0.83 | CA2 (0.36) | CA2 | |
| Dimethyl Methylphosphonate SCHEMBL7159496 | 0.80 | CA2 (0.47) | CA2 | |
| Dimethyl Methylphosphonate SCHEMBL29023322 | 0.80 | CA2 (0.57) | CA2 | |
| Dimethyl Methylphosphonate SCHEMBL7162647 | 0.80 | CA2 (0.47) | CA2 | |
| Dimethyl Methylphosphonate SCHEMBL626094 | 0.79 | — | — | |
| Dimethyl Methylphosphonate SCHEMBL27738075 | 0.79 | — | — | |
| Dimethyl Methylphosphonate SCHEMBL30950306 | 0.79 | — | — | |
| Dimethyl Methylphosphonate SCHEMBL27763775 | 0.79 | — | — | |
| Dimethyl Methylphosphonate SCHEMBL28200426 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111655806-B | Polyester amide, process for producing the same, and polyester amide composition | 伊士曼化工公司 | 2023-12-05 | — | — | CN | disclosed |
| CN-111630122-B | Novel polyesteramide, process for producing the same and polyesteramide composition | 伊士曼化工公司 | 2023-07-28 | — | — | CN | disclosed |
| CN-111225964-A | Semiconductor luminescent nanoparticles | 默克专利股份有限公司 | 2020-06-02 | — | — | CN | disclosed |
| US-7973109-B2 | Crosslinked type layered metal phosphonate compound, production process therefor, non-crosslinked type layered metal phosphonate compound, production process therefor, as well as stock solution | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2011-07-05 | — | — | US | disclosed |
| US-20090093607-A1 | Crosslinked type layered metal phosphonate compound, production process therefor, non-crosslinked type layered metal phosphonate compound, production process therefor, as well as stock solution | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2009-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090093607-A1 | Crosslinked type layered metal phosphonate compound, production process therefor, non-crosslinked type layered metal phosphonate compound, production process therefor, as well as stock solution | WEE1, WEE2, PPIP5K2 | CA2 2108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.